Literature DB >> 6407345

Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species.

R Badaró, S G Reed, E M Carvalho.   

Abstract

This study was designed to determine which morphologic form and species of Leishmania is most suitable for detection of antibody in sera from American visceral leishmaniasis (AVL) patients by the indirect fluorescent antibody test (IFAT). Promastigotes and amastigotes of Leishmania mexicana or Leishmania donovani chagasi were used as sources of antigen. A total of 70 sera, including 30 from AVL patients, 30 from healthy subjects and 10 from Chagas' disease patients, were used in the study. Titers of antibody up to a dilution of 1:64 were found with all four antigens. At a titer of 1:128, the sensitivity of the IFAT using L. d. chagasi promastigotes as a source of antigen was 100% and the specificity at a titer of 1:32 was 98%. Although the sensitivity of the amastigote forms was close to 100% at a similar titer, the specificity at a titer of 32 using the L. d. chagasi amastigotes was 91% and using L. mexicana amastigotes was only 80%. The L. d. chagasi promastigote antigen was also the one that showed less cross reaction with sera from Chagas' disease patients. Since cross reactivity between Trypanosoma cruzi and Leishmania species is well known in serological tests, and minimizing of such cross reactivity is of critical importance for diagnosis, we suggest that L. d. chagasi promastigotes should be the antigen of choice for diagnosis of visceral leishmaniasis by IFAT in areas also endemic for trypanosomiasis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407345     DOI: 10.4269/ajtmh.1983.32.480

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

1.  Immunoenzymatic assay for the diagnosis of American tegumentary leishmaniasis using soluble and membrane-enriched fractions from infectious Leishmania (Viannia) braziliensis.

Authors:  Jamyra Iglesias Cataldo; Fernanda Carvalho de Queiroz Mello; Eliame Mouta-Confort; Maria de Fátima Madeira; Armando de Oliveira Schubach; Marcelo da Silva Genestra; Flávia Coelho Ribeiro; Célia de Fátima Moreira-Venâncio; Sônia Regina Lambert Passos
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Cloning, characterization, and serodiagnostic evaluation of Leishmania infantum tandem repeat proteins.

Authors:  Yasuyuki Goto; Rhea N Coler; Jeffrey Guderian; Raodoh Mohamath; Steven G Reed
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Leishmania major-like antigen for specific and sensitive serodiagnosis of human and canine visceral leishmaniasis.

Authors:  Rosângela Barbosa-De-Deus; Marcos Luíz Dos Mares-Guia; Adriane Zacarias Nunes; Kátia Morais Costa; Roberto Gonçalves Junqueira; Wilson Mayrink; Odair Genaro; Carlos Alberto Pereira Tavares
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis.

Authors:  V L da Matta; S Hoshino-Shimizu; R Dietze; C E Corbett
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

5.  Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis.

Authors:  Israel Cruz; Carmen Chicharro; Javier Nieto; Begoña Bailo; Carmen Cañavate; María-Concepción Figueras; Jorge Alvar
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

6.  Induction of complement-sensitivity in Leishmania amazonensis metacyclic promastigotes by protease treatment but not by specific antibodies.

Authors:  N M Soares; E M Carvalho; R T Pinho; L C Pontes de Carvalho
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

7.  Detection of Leishmania infantum in dogs by PCR with lymph node aspirates and blood.

Authors:  S Reale; L Maxia; F Vitale; N S Glorioso; S Caracappa; G Vesco
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

8.  Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.

Authors:  Robert G Schaut; Tara L Grinnage-Pulley; Kevin J Esch; Angela J Toepp; Malcolm S Duthie; Randall F Howard; Steven G Reed; Christine A Petersen
Journal:  Vaccine       Date:  2016-09-21       Impact factor: 3.641

9.  Purification and characterization of an 80-kilodalton membrane protein from Leishmania donovani.

Authors:  A C White; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis.

Authors:  C Fargeas; M Hommel; R Maingon; C Dourado; M Monsigny; R Mayer
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.